University of Rochester Medical Center | Wilmot Cancer Institute
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of University of Rochester Medical Center
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
The purpose of this study is to assess the safety and efficacy of Navlimetostat (BMS-986504), a selective, MTA-cooperative PRMT5 inhibitor, in combin...
This study will include two groups of patients: Cohort 1 and Cohort 2.Cohort 1: will help researchers learn how a medicine called imlunestrant (LY348...
The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast c...
The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in part...
The purpose of this study is to test a new medicine, vepugratinib, in comparison with placebo, to see if it is safe and can help people with a bladde...
Older patients with diffuse large B- cell lymphoma (DLBCL) do not have the same rates of disease control as younger patients and are at risk for toxi...
Trial sponsors
Clinical trials
Research sites
Resources
Legal